Human peritoneal tight junction, transporter and channel expression in health and kidney failure, and associated solute transport.
Eszter Levai, Iva Marinovic, Maria Bartosova...
https://pubmed.ncbi.nlm.nih.gov/37833387/Actively Recruiting
Led by Heidelberg University · Updated on 2026-04-30
500
Participants Needed
26
Research Sites
13 weeks
Total Duration
Researchers are investigating the changes in the peritoneal membrane of children and adults undergoing peritoneal dialysis PD, focusing on early tissue and vascular changes that occur during treatment. The study aims to understand how the membrane transforms over time, leading to complications such as fibrosis, blood vessel changes, and loss of membrane function, which can cause PD to fail. This international, prospective study includes children with kidney failure and those receiving PD, as well as healthy individuals undergoing abdominal surgery for comparison. The study involves collecting peritoneal membrane biopsies during clinically required surgeries, such as catheter insertion, hernia repair, catheter exchange, and kidney transplantation. Biopsies and tissue samples are analyzed using detailed histomorphometry and protein expression to relate structural changes to PD treatment types, duration, and functional outcomes. Blood samples are taken during routine clinical care to study inflammation and cardiovascular markers. The study also includes patients after kidney transplantation to evaluate the membranes response post-PD. Participants will undergo surgery for clinical reasons where tissue samples are collected without significantly increasing surgical time or risk. Researchers will measure vessel changes in the peritoneal membrane and correlate findings with PD treatment time and other health factors. The study tracks these changes over several years, with the main outcome being the degree of blood vessel disease in the membrane after two years of PD treatment. Overall, the study may provide insights to optimize PD treatment based on individual membrane characteristics.
CONDITIONS
International (Pediatric) Peritoneal Biobank
C
Claus P Schmitt, Prof
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Heidelberg University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Occurs at the time of clinical procedures
Participants undergo biopsy sampling during routine abdominal surgeries or catheter procedures for tissue analysis.
1 to 3 visits depending on surgery or catheter removal timing
Duration - Up to 2 years
Participants are followed to observe peritoneal and kidney health over time after biopsy sampling.
Follow-up visits as part of routine care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Eszter Levai, Iva Marinovic, Maria Bartosova...
https://pubmed.ncbi.nlm.nih.gov/37833387/Maria Bartosova, Conghui Zhang, Betti Schaefer...
https://pubmed.ncbi.nlm.nih.gov/34233458/Rusan Ali Catar, Maria Bartosova, Edyta Kawka...
https://pubmed.ncbi.nlm.nih.gov/35185912/Heidelberg University
Lead Sponsor